Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.34 |
| ▸ | TERT | O14746 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | DPP4 | P27487 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8397363 | 0.98 | TDP1 (0.39) | TDP1MCL1TERTKMT2AMEN1 | |
| SCHEMBL21153346 | 0.84 | MCL1 (0.48) | MCL1TERTKMT2AMEN1POLB | |
| SCHEMBL12035873 | 0.81 | — | — | |
| SCHEMBL29311849 | 0.80 | TDP1 (0.39) | TDP1KMT2AMEN1PSMB5 | |
| SCHEMBL21440848 | 0.80 | MCL1 (0.35) | TDP1MCL1TERTKMT2AMEN1 | |
| SCHEMBL24393668 | 0.80 | MCL1 (0.35) | TDP1MCL1TERTKMT2AMEN1 | |
| SCHEMBL21440822 | 0.80 | MCL1 (0.35) | TDP1MCL1TERTKMT2AMEN1 | |
| SCHEMBL25661969 | 0.80 | MCL1 (0.35) | TDP1MCL1TERTKMT2AMEN1 | |
| SCHEMBL1329299 | 0.80 | FAAH (0.42) | TDP1MCL1TERTKMT2AMEN1 | |
| SCHEMBL1790228 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240228671-A1 | POLYPEPTIDYL LINKERS | Quantum-Si Incorporated (US) | 2024-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240228671-A1 | POLYPEPTIDYL LINKERS | VIP, DNPEP, PREP | TDP1 2663/4885MCL1 4381/4885TERT 2965/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.